May 11, 2011Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders
Apr 20, 2011Anavex First-in-Human Dosing Commenced in ANAVEX 2-73 Clinical Trial for Alzheimer's Disease